These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25803686)

  • 1. CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.
    Martinez LM; Labovsky V; Calcagno ML; Davies KM; Garcia Rivello H; Bianchi MS; Wernicke A; Fernández Vallone VB; Chasseing NA
    PLoS One; 2015; 10(3):e0121421. PubMed ID: 25803686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer.
    Labovsky V; Martinez LM; Calcagno ML; Davies KM; García-Rivello H; Wernicke A; Feldman L; Giorello MB; Matas A; Borzone FR; Howard SC; Chasseing NA
    Tumour Biol; 2016 Oct; 37(10):13377-13384. PubMed ID: 27460086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases.
    Martinez LM; Labovsky V; Calcagno Mde L; Davies KM; Rivello HG; Wernicke A; Calvo JC; Chasseing NA
    Pathol Res Pract; 2016 Apr; 212(4):350-5. PubMed ID: 26872535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Giercksky KE; Nesland JM
    Clin Cancer Res; 2008 Apr; 14(8):2341-50. PubMed ID: 18413823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
    Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
    Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival.
    Davidson B; Stavnes HT; Førsund M; Berner A; Staff AC
    Breast; 2010 Dec; 19(6):493-8. PubMed ID: 21078485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer.
    Labovsky V; Martinez LM; Davies KM; de Luján Calcagno M; García-Rivello H; Wernicke A; Feldman L; Matas A; Giorello MB; Borzone FR; Choi H; Howard SC; Chasseing NA
    BMC Cancer; 2017 Apr; 17(1):280. PubMed ID: 28420351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
    Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
    Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.
    Gluz O; Wild P; Liedtke C; Kates R; Mendrik H; Ehm E; Artinger V; Diallo-Danebrock R; Ting E; Mohrmann S; Poremba C; Harbeck N; Nitz U; Hartmann A; Gaumann A
    Breast Cancer Res Treat; 2011 Apr; 126(3):643-51. PubMed ID: 21318601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
    Ali AM; Ueno T; Tanaka S; Takada M; Ishiguro H; Abdellah AZ; Toi M
    Eur J Cancer; 2011 Oct; 47(15):2265-72. PubMed ID: 21737256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
    Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
    Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
    Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
    Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtissue density prognostic factor evaluation based on antigens CD34 and CD 105 in ovarian cancer patients.
    Cwiklnska A; Sobstyl M; Kwasniewski W; Bednarek W
    Ann Agric Environ Med; 2013; 20(4):838-42. PubMed ID: 24364465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.